Drug discovery hotspots: India’s Genome Valley
Drug Discovery World
APRIL 10, 2023
Although pharmaceutical companies had previously been risk-averse and investment in R&D was lower than other countries, leading organisations are looking to increase research spending to 10-12% over the next few years, with biologics and novel chemical entities dominating 4. In 2021, a DDW article stated: “There is work to be done.
Let's personalize your content